The association between subclass-specific IgG Fc N-glycosylation The association between subclass-specific IgG Fc N-glycosylation profiles and hypertension in the Uygur, Kazak, Kirgiz, and Tajik profiles and hypertension in the Uygur, Kazak, Kirgiz, and Tajik populations populations

ABSTRACT

[1]  Zuo Chen,et al.  Status of Hypertension in China: Results From the China Hypertension Survey, 2012–2015 , 2018, Circulation.

[2]  Youxin Wang,et al.  Immunoglobulin G N-Glycans as Potential Postgenomic Biomarkers for Hypertension in the Kazakh Population. , 2017, Omics : a journal of integrative biology.

[3]  C. Gieger,et al.  Effects of statins on the immunoglobulin G glycome. , 2017, Biochimica et biophysica acta. General subjects.

[4]  F. Vučković,et al.  Effects of allergic diseases and age on the composition of serum IgG glycome in children , 2016, Scientific Reports.

[5]  Youxin Wang,et al.  The Uyghur population and genetic susceptibility to type 2 diabetes: potential role for variants in CAPN10,APM1 and FUT6 genes , 2016, Journal of cellular and molecular medicine.

[6]  I. Rudan,et al.  The Association Between Glycosylation of Immunoglobulin G and Hypertension , 2016, Medicine.

[7]  Gillian Dekkers,et al.  IgG Subclasses and Allotypes: From Structure to Effector Functions , 2014, Front. Immunol..

[8]  Xiong Yang,et al.  Genetic architectures of ADME genes in five Eurasian admixed populations and implications for drug safety and efficacy , 2014, Journal of Medical Genetics.

[9]  F. Nimmerjahn,et al.  The role of Fc receptors and complement in autoimmunity. , 2013, Autoimmunity reviews.

[10]  C. Franceschi,et al.  N-glycomic biomarkers of biological aging and longevity: A link with inflammaging , 2013, Ageing Research Reviews.

[11]  I. Rudan,et al.  High-throughput IgG Fc N-glycosylation profiling by mass spectrometry of glycopeptides. , 2013, Journal of proteome research.

[12]  Alan D. Lopez,et al.  A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[13]  G. Lauc,et al.  Alternative glycosylation modulates function of IgG and other proteins - implications on evolution and disease. , 2012, Biochimica et Biophysica Acta.

[14]  P. Taylor,et al.  Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcγRIIB and dectin-1 , 2012, Nature Medicine.

[15]  Magnus Palmblad,et al.  Fc specific IgG glycosylation profiling by robust nano-reverse phase HPLC-MS using a sheath-flow ESI sprayer interface. , 2012, Journal of proteomics.

[16]  Ayellet V. Segrè,et al.  Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis , 2010, Nature Genetics.

[17]  André M Deelder,et al.  Glycosylation profiling of immunoglobulin G (IgG) subclasses from human serum , 2007, Proteomics.

[18]  F. Zhai,et al.  [Status and characteristic of dietary intake of 12 minority nationalities in China]. , 2007, Wei sheng yan jiu = Journal of hygiene research.

[19]  J. Ravetch,et al.  Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation , 2006, Science.

[20]  Jing Chen,et al.  Prevalence, Awareness, Treatment, and Control of Hypertension in China , 2002, Hypertension.

[21]  J. Axford,et al.  A detailed lectin analysis of IgG glycosylation, demonstrating disease specific changes in terminal galactose and N-acetylglucosamine. , 1997, Journal of autoimmunity.

[22]  A. Varki,et al.  Biological roles of oligosaccharides: all of the theories are correct , 1993, Glycobiology.

[23]  R. Dwek,et al.  A comparative analysis of disease-associated changes in the galactosylation of serum IgG. , 1989, Journal of autoimmunity.

[24]  R. Dwek,et al.  Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG , 1985, Nature.

[25]  G. Lauc,et al.  Complex Genetics of Protein N -Glycosylation , 2014 .

[26]  I. Rudan,et al.  Suboptimal health: a potential preventive instrument for non-communicable disease control and management: Screening novel biomarkers for metabolic syndrome by profiling human plasma N-glycans in Chinese Han and Croatian populations , 2012 .

[27]  A. Alwan.  Global status report on noncommunicable diseases 2010. , 2011 .

[28]  K. Jauch,et al.  † These authors contributed equally to this work. , 2009 .

[29]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[30]  J. Uhl.  Research who? , 1991, Journal of professional nursing : official journal of the American Association of Colleges of Nursing.